1. Volume 81, Issue 7, Pages 698-706 (April 2012)
Comparative effectiveness of incident oral antidiabetic drugs on kidney function 
Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff, T Alp Ikizler, Marie R. Griffin 
Kidney International 
Volume 81, Issue 7, Pages (April 2012)
DOI: /ki
Copyright © 2012 International Society of Nephrology Terms and Conditions

2. Figure 1
Flowchart of eligible patients. eGFR, estimated glomerular filtration rate; OAD, oral antidiabetic drug; VA, Veterans Affairs.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

3. Figure 2
Crude cumulative incidence of the composite outcome (persistent reduction of baseline estimated glomerular filtration rate of 25% or end-stage renal disease by oral antidiabetic drug exposure group).
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

4. Figure 3
Adjusted hazard ratios for the composite outcome of glomerular filtration rate event or end-stage renal disease among age, race, HbA1c, and renin–angiotensin–aldosterone system blockade subgroups. Hazard ratios greater than 1 demonstrate an increased risk for composite outcome with sulfonylurea compared with metformin. ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions